Founded in 2017, Fosun Lead (Shanghai) Pharmaceutical Technology Co., Ltd. is an innovation incubation platform of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in the field of biomedical science and technology, with its address at Building 1, Intelligent Healthcare Industrial Base, Zhangjiang Hi-Tech Park, No. 1111, Zhongshan North 1st Road, Hongkou District, Shanghai, covering an area of more than 3,000 square meters. It has mature functional biomedical experimental R&D sites, GMP workshops and business offices.

Under the guidance of Prof. Xu Tian, Chief Scientific Adviser to Fosun Pharma, Chair Professor of Genetics and Vice President of Westlake University, Fosun Lead focuses on the cutting-edge fields of biotechnology and information technology, including subdivisional fields like cell & gene therapy, precision medicine of oncology, tumor immunology, microbial flora, POCT and artificial intelligence by tackling the difficulties in the joint research of multidisciplinary teams through the "In-depth Incubation" model based on the long-term mechanism. It is committed to the transformation and industrialization of scientific and technological achievements oriented by unmet clinical demands. Following the "talent-driven" strategy, Fosun Lead and various project companies, including OECE Therapeutics, have nearly 70 employees majoring in Medicine, Biology, Polymer Material, Immunology, Microbiology, Pharmacy, Biological Information, Artificial Intelligence, Data Analysis and other disciplines, of which nearly 35% have doctoral degrees and more than 70% have master's degrees or above.

To lead far, a wise man always keeps the innovation going. This is Fosun Lead's firm belief and program of action. Taking advantage of the industrial resources of Fosun Pharma and the ecological system of Fosun, Fosun Lead has established close cooperation relationships with Chinese and foreign well-known universities, research institutes and medical research institutions to advance the rapid verification of innovative technologies and product development and application, thus providing more care to our beloved with scientific and technological innovation.

Located in the United States, FUSION (Fosun Pharma US Innovation Hub) has a team with senior R&D experience and is committed to exploring, evaluating and strategically investing in early scientific and technological innovation and projects with blockbuster potentials. It focuses on incubating startups with technological platforms or abundant pipelines, or acquiring global (for early projects) or Chinese (for late projects) interests in innovator drugs.